Drug Safety

, Volume 19, Issue 4, pp 325–337 | Cite as

Treating Gastro-Oesophageal Reflux Disease During Pregnancy and Lactation

What are the Safest Therapy Options?
  • Crystal N. Broussard
  • Joel E. Richter
Drug Safety Concepts

Abstract

Gastro-oesophageal reflux and heartburn are reported by 45 to 85% of women during pregnancy. Typically, the heartburn of pregnancy is new onset and is precipitated by the hormonal effects of estrogen and progesterone on lower oesophageal sphincter function. In mild cases, the patient should be reassured that reflux is commonly encountered during a normal pregnancy: lifestyle and dietary modifications may be all that are required.

In a pregnant woman with moderate to severe reflux symptoms, the physician must discuss with the patient the benefits versus the risks of using drug therapy. Medications used for treating gastrooesophageal reflux are not routinely or vigorously tested in randomised, controlled trials in women who are pregnant because of ethical and medico-legal concerns. Safety data are based on animal studies, human case reports and cohort studies as offered by physicians, pharmaceutical companies and regulatory authorities.

If drug therapy is required, first-line therapy should consist of nonsystemically absorbed medications, including antacids or sucralfate, which offer little, if any, risk to the fetus. Systemic therapy with histamine H2 receptor antagonists (avoiding nizatidine) or prokinetic drugs (metoclopramide, cisapride) should be reserved for patients with more severe symptoms. Proton pump inhibitors are not recommended during pregnancy except for severe intractable cases of gastrooesophageal reflux or possibly prior to anaesthesia during labour and delivery. In these rare situations, animal teratogenicity studies suggests that lansoprazole may be the best choice. Use of the least possible amount of systemic drug needed to ameliorate the patient’s symptoms is clearly the best for therapy. If reflux symptoms are intractable or atypical, endoscopy can safely be performed with conscious sedation and careful monitoring the mother and fetus.

Keywords

Adis International Limited Omeprazole Ranitidine Metoclopramide Lansoprazole 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Olans LB, Wolf JL. Gastroesophageal reflux in pregnancy. Gastrointest Endosc Clin N Am 1994; 4(4): 699–713PubMedGoogle Scholar
  2. 2.
    Torbey CF, Richter JE. Gastrointestinal motility disorders in pregnancy. Semin Gastrointest Dis 1995; 6(4): 201–16Google Scholar
  3. 3.
    Castro L. Reflux esophagitis as the cause of heartburn in pregnancy. Am J Obstet Gynecol 1967; 98: 1–10Google Scholar
  4. 4.
    Marrero JM, Goggin PM, de Caestecker JS, et al. Determinants of pregnancy heartburn. Br J Obstet Gynaecol 1992; 99: 731–4PubMedCrossRefGoogle Scholar
  5. 5.
    Everson GT. Gastrointestinal motility in pregnancy. Gastroenterol Clin N Am 1992; 21(4): 751–76Google Scholar
  6. 6.
    Bainbridge ET, Nicholas SD, Newton JR, et al. Gastro-esophageal reflux in pregnancy. Scand J Gastroenterol 1984; 19: 85–9PubMedGoogle Scholar
  7. 7.
    Bassey OO. Pregnancy heartburn in Nigerians and Caucasians with theories about aetiology based on manometric recordings from the oesophagus and stomach. Br J Obstet Gynaecol 1977; 84: 439–43PubMedCrossRefGoogle Scholar
  8. 8.
    Bainbridge ET, Temple JG, Nicholas SP, et al. Symptomatic gastrooesophageal reflux in pregnancy: a comparative study of white Europeans and Asians in Birmingham. Br J Clin Pract 1983; 37: 53–7PubMedGoogle Scholar
  9. 9.
    Baron TH, Richter JE. Gastroesophageal reflux disease in pregnancy. Gastroenterol Clin N Am 1992; 21(4): 777–91Google Scholar
  10. 10.
    Van Thiel DH, Gavaler JS, Stremple J. Heartburn of pregnancy. Gastroenterology 1977; 72: 666–8PubMedGoogle Scholar
  11. 11.
    Fisher RS, Roberts GS, Grabowski CJ, et al. Altered lower esophageal sphincter function during early pregnancy. Gastroenterology 1978; 74: 1233–7PubMedGoogle Scholar
  12. 12.
    Fisher RS, Roberts GS, Grabowski CJ, et al. Inhibition of lower esophageal sphincter circular muscle by female sex hormones. Am J Physiol 1978; 234: E243–7PubMedGoogle Scholar
  13. 13.
    Schulze K, Christensen. Lower esophageal sphincter of the opossum esophagus in pseudopregnancy. Gastroenterology 1977; 73: 1082–5PubMedGoogle Scholar
  14. 14.
    Van Thiel DH, Gravaler JS, Stremple J. Lower esophageal sphincter pressure in women using sequential oral contraceptives. Gastroenterology 1976; 71: 232–4PubMedGoogle Scholar
  15. 15.
    Fillippone M, Malmud L, Kryston L, et al. Esophageal and LES pressures (LESP) in male transsexuals treated with female sex hormones [abstract]. Clin Res 1983; 31: 282AGoogle Scholar
  16. 16.
    Macfie AG, Magides AD, Richmond MN et al. Gastric emptying in pregnancy. Br J Anaesth 1991; 67: 54–7PubMedCrossRefGoogle Scholar
  17. 17.
    Whitehead EM, Smith M, Dean Y, et al. An evaluation of gastric emptying times in pregnancy and the puerperium. Anaesthesia 1993; 48: 53–7PubMedCrossRefGoogle Scholar
  18. 18.
    Sandhar BK, Elliott RH, Windram I, et al. Peripartum changes in gastric emptying. Anaesthesia 1992; 47: 196–8PubMedCrossRefGoogle Scholar
  19. 19.
    O’Sullivan GM, Sutton AJ, Thompson SA, et al. Noninvasive measurement of gastric emptying in obstetric patients. Anesth Analg 1987; 66: 505–11PubMedCrossRefGoogle Scholar
  20. 20.
    Spence AA, Moir DD, Finlay WEI. Observations on intragastric pressure. Anaesthesia 1967; 22: 249–56PubMedCrossRefGoogle Scholar
  21. 21.
    Van Thiel DH, Wald A. Evidence refuting a role for increasing abdominal pressure in the pathogenesis of heartburn associated with pregnancy. Am J Obstet Gynecol 1981; 140: 420–2PubMedGoogle Scholar
  22. 22.
    Cappell MS, Colon VJ, Sidhom OA. A study of eight medical centers of the safety and clinical efficacy of es-ophagogastroduodenoscopy in 83 pregnant females with follow-up of fetal outcome with comparison to control groups. Am J Gastroenterol 1996; 91(2): 348–54PubMedGoogle Scholar
  23. 23.
    Lewis JH, Weingold AB, The committee on FDA-related matters, American college of gastroenterology. The use of gastrointestinal drugs during pregnancy and lactation. Am J Gastroenterol 1985; 80(11): 912–23PubMedGoogle Scholar
  24. 24.
    Niebyl JR. Teratology and drug use during pregnancy and lactation. In: Scott JR, Isaia PD, Hammond C, et al., editors. Dansforths obstetrics and gynecology. 7th ed. Philadelphia: WB Saunders, 1994: 225–44Google Scholar
  25. 25.
    Saunders EJ, Saunders JA. Drug therapy in pregnancy: the lesson of diethylstibestrol, thalidomide and bendectin. Health Care Women Int 1989; 11: 423–32CrossRefGoogle Scholar
  26. 26.
    Witter FR, King TM, Blake D. The effects of chronic gastrointestinal medication on the fetus and neonate. Obstet Gynecol 1981; 58(5 Suppl.): 79–84Google Scholar
  27. 27.
    Hill LM, Kleinberf F. Effects of drugs and chemicals on the fetus and newborn. Mayo Clin Proc 1984; 59: 707–16PubMedGoogle Scholar
  28. 28.
    Ching C, Lam S. Antacids: indications and limitations. Drugs 1994; 47: 305–17PubMedCrossRefGoogle Scholar
  29. 29.
    Physicians desk reference. 51st ed. Montvale (NJ): Medical Economics Company Inc., 1997Google Scholar
  30. 30.
    Ranchet G, Gangemi O, Petrone M. Sucralfate in the treatment of gravidic pyrosis. G Ital Ostericia Ginecol 1990; 12: 1–16Google Scholar
  31. 31.
    Anand S, Van Thiel DH. Prenatal and neonatal exposure to cimetidine results in gonadal and sexual dysfunction in adult males. Science 1982; 218: 441–5CrossRefGoogle Scholar
  32. 32.
    Parker S, Schade RR, Pohl CR, et al. Prenatal and neonatal exposure of male rat pups to cimetidine but not ranitidine adversely affects subsequent adult sexual functioning. Gastroenterology 1984; 86: 675–80PubMedGoogle Scholar
  33. 33.
    Zulli P, Di Nisio Q. Cimetidine treatment during pregnancy. Lancet 1982; 2: 945–6Google Scholar
  34. 34.
    Corrazza GR. Cimetidine (’Tagamet) in peptic ulcer therapy during pregnancy. Clin Trial J 1982; 19: 91–3Google Scholar
  35. 35.
    Glade G, Saccar CL, Pereira GR. Cimetidine in pregnancy: apparent transient liver impairment in the newborn. Am J Dis Child 1980; 134: 87–8PubMedGoogle Scholar
  36. 36.
    Briggs G, Freeman R, Yaffe S, editors. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal medicine. 4th ed. Baltimore: Williams and Wilkins, 1994Google Scholar
  37. 37.
    Somogyi A, Gugler R. Cimetidine excretion into breast milk. Br J Clin Pharmacol 1979; 7: 627–9PubMedCrossRefGoogle Scholar
  38. 38.
    Leslie GB, Walker TF. A toxicological profile of cimetidine. In: Burland WL, Simkins MA, editors. Cimetidine: proceedings of the Second International Symposium on histamine H2-receptor antagonists. Amsterdam: Excerpta Medica, 1977: 24–33Google Scholar
  39. 39.
    Blyth DI. Some effects of histamine in the depolarized rat uterus. Br J Pharmacol 1973; 49: 445–56PubMedCrossRefGoogle Scholar
  40. 40.
    McGowan WAW Safety of cimetidine in obstetric patients. J R Soc Med 1979; 72: 902–7PubMedGoogle Scholar
  41. 41.
    Ostheimer GW, Morrison JA, Lavoie C, et al. The effect of cimetidine on mother, newborn and neonatal behavior [abstract]. Anesthesiology 1982; 57: A405CrossRefGoogle Scholar
  42. 42.
    Cipriani S, Conti R, Vella G. Ranitidine in pregnancy: three case reports. Clin Eur 1983; 22(1): 1–6Google Scholar
  43. 43.
    Beeley L. Does ranitidine have an adverse effect on a pregnant women or her fetus? BMJ 1985; 290: 308CrossRefGoogle Scholar
  44. 44.
    Armentano G, Bracco PL, Di Silverio C. Ranitidine in the treatment of reflux esophagitis in pregnancy. Clin Exp Obstet Gynecol 1989; 16: 130–3PubMedGoogle Scholar
  45. 45.
    Koren G, Zemlickis DM. Outcome of pregnancy after first trimester exposure to H2 receptor antagonists. Ann J Perinatol 1991; 8: 37–8CrossRefGoogle Scholar
  46. 46.
    Larson JD, Patatanian E, Miner PB, et al. Double-blind, placebo-controlled study of ranitidine for gastroesophageal reflux symptoms during pregnancy. Obstet Gynecol 1997; 90(1): 83–7PubMedCrossRefGoogle Scholar
  47. 47.
    Savarino V, Giusti M, Scalabrini P, et al. Famotidine has nosignificant effect on gonadal function in man. Gastroenterol Clin Biol 1988; 12(1): 19–22PubMedGoogle Scholar
  48. 48.
    Anderson PO. Drug use during breast feeding. Clin Pharm 1991; 10: 594–624PubMedGoogle Scholar
  49. 49.
    Michaletz-Onody PA. Peptic ulcer disease in pregnancy. Gastroenterol Clin N Am 1992; 21: 817–26Google Scholar
  50. 50.
    Neubauer BL, Goode RL, Best KL, et al. Endocrine effects of a new histamine H2-receptor antagonist, nizatidine (LY139037), in the male rat. Toxicol Appl Pharmacol 1990; 102: 219–32PubMedCrossRefGoogle Scholar
  51. 51.
    Morton DM. Pharmacology and toxicology of nizatidine. Scand J Gastroenterol 1987; 22 (Suppl. 136): 1–8CrossRefGoogle Scholar
  52. 52.
    Magee LA, Inoncencion G, Kamboj L, et al. Safety of first trimester exposure to histamine H2-blockers: a prospective cohort study. Dig Dis Sci 1996; 41: 1145–9PubMedCrossRefGoogle Scholar
  53. 53.
    Desmond PV, Watson KJR. Metoclopramide: a review. Med J Aust 1986; 144: 366–9PubMedGoogle Scholar
  54. 54.
    Arvela P, Jouppila R, Kauppila A, et al. Placental transfer and hormonal effects of metoclopramide. Eur J Clin Pharmacol 1983; 25: 345–8CrossRefGoogle Scholar
  55. 55.
    Bailey B, Addis A, Lee A, et al. Cisapride use during human pregnancy: a prospective, controlled multicenter study. Dig Dis Sci 1997; 42(9): 1848–52PubMedCrossRefGoogle Scholar
  56. 56.
    Adamo S, Carrara M, Azzurro M, et al. Omeprazole treatment during first month of pregnancy: a case report. Ital J Gastroenterol 1993; 25 (Suppl. 1): 1–198Google Scholar
  57. 57.
    Harper MA, McVeigh JE, Thompson W, et al. Successful pregnancy in association with zollinger-ellison syndrome. Am J Obstet Gynecol 1995; 13: 863–4CrossRefGoogle Scholar
  58. 58.
    Glasbrenner B, Swobodnik W, Malfertheiner P, et al. Severe hyperemesis gravidarum-pathophysiologic observations and new therapeutic approach [in German]. Z Gastroenterol 1991; 29(4): 163–6PubMedGoogle Scholar
  59. 59.
    Tsirigotis M, Yazdani N, Craft I. Potential effects of omeprazole in pregnancy [letter]. Hum Reprod 1995 Aug; 10(8): 2177–8PubMedGoogle Scholar
  60. 60.
    Kurinczuk J, Bower C. Birth defects in infants conceived by intracytoplasmic sperm injection: an alternative interpretation. BMJ 1997; 315: 1260–6PubMedCrossRefGoogle Scholar
  61. 61.
    Bylsma-Howell M, Riggs KW, McMorland GH, et al. Placental transport of metoclopramide: assessment of maternal and neonatal effects. Can Anaesth Soc J 1983; 30: 487–92PubMedCrossRefGoogle Scholar
  62. 62.
    Vanner RG, Goodman NW. Gastro-oesophageal reflux in pregnancy at term and after delivery. Anaesthesia 1989; 44: 808–11PubMedCrossRefGoogle Scholar
  63. 63.
    Parkman HP, Baron TH, Richter JE, et al. Gastrointestinal motility disorders during pregnancy. In: Karlstadt RG, Surawicz Cm, Croitoru R, editors. Gastrointestinal disorders during Pregnancy. Am Coll Gastroenterol 1994: 4-14Google Scholar
  64. 64.
    Lewis RT, Burgess JH, Hempson LG. Cardiorespiratory studies in critical illness: changes in aspiration pneumonitis. Arch Surg 1971; 103: 335–40PubMedCrossRefGoogle Scholar
  65. 65.
    Picca SM, Fiordalisi J. Treatment of gastrointestinal motility disorders in pregnancy. Ann Intern Med 1993; 119(7 Pt 1): 635PubMedGoogle Scholar
  66. 66.
    Cheek TG, Gutsche BB. Pulmonary aspiration of gastric contents. In: Scnider SM, Levinson G, editors. Anesthesia for Obstetrics. Baltimore: Williams and Wilkins, 1993: 407–31Google Scholar
  67. 67.
    Hodgkinson R, Glassenberg R, Joyce TH, et al. Comparison of cimetidine (Tagamet) with antacid for safety and effectiveness in reducing gastric acidity before elective cesarean section. Anesthesiology 1983; 59: 86–90PubMedCrossRefGoogle Scholar
  68. 68.
    Moore J, Flynn RJ, Sampaio M, et al. Effect of single-dose omeprazole on intragastric acidity and volume during obstetric anaesthesia. Anaesthesia 1989; 44: 559–62PubMedCrossRefGoogle Scholar
  69. 69.
    Orr DA, Bill KM, Gillon KRW, et al. Effects of omeprazole, with and without metoclopramide, in elective obstetric anaesthesia. Anaesthesia 1993; 48: 114–9PubMedCrossRefGoogle Scholar
  70. 70.
    Brock-Utne JG, Dow TG, Welman S, et al. The effect of metoclopramide in the lower oesophageal sphincter in late pregnancy. Anaesth Intensive Care 1978; 6: 26–9PubMedGoogle Scholar

Copyright information

© Adis International Limited 1998

Authors and Affiliations

  • Crystal N. Broussard
    • 1
  • Joel E. Richter
    • 1
  1. 1.Department of Gastroenterology-S40The Cleveland Clinic FoundationClevelandUSA

Personalised recommendations